On Tuesday, April 9th the Seattle graduate campus hosted the “Xconomy Forum: Biotech in the Belt-Tightening Era.” There were over 150 people in attendance with backgrounds from many sectors of business, technology, and healthcare.
The National Biotechnology Editor at Xconomy, Luke Timmerman, moderated the discussion. Dean Tayloe Washburn gave opening remarks before scheduled speakers took the stage to discuss topics in healthcare and biotechnology. Some notable trends in these industries were emerging focus on value, novel financing models, and the use of Big Data.
Mitch Gold, Founder and Chairman, Alpine Biosciences
Mark Litton, Co-founder and Chief Business Officer, Alder Biopharma
Al Luderer, CEO, Integrated Diagnostics
Kim Popovits, CEO, Genomic Health
Scott Ramsey, Director, ICORE/Fred Hutchinson Cancer Research Center
Chad Robins, CEO, Adaptive Biotechnologies
Clay Siegall, CEO, Seattle Genetics
Risa Stack, General Manager, GE Healthymagination
Robert Nelsen, Managing Director, Arch Venture Partners
See Xconomy’s recap here.